This stage of the condition may influence an individual’s clinical features by increasing the frequency of blunt ocular trauma and the degree of intraocular inflammation.
More patients on topical therapy achieved at least a 20% IOP reduction, but the laser procedure was better at reducing the need for glaucoma surgeries, number of meds and incidence of ocular adverse effects.
Overexpression may damage retinal ganglion cells and/or impair aqueous outflow. Researchers hope the association may play a future role as a biomarker of early disease activity.